This research examines the effectiveness and safety of inhaled pharmacotherapy for patients with pneumoconiosis and airway obstruction.
Retrospective cohort study design
Analysis of patient records from clinical settings in China
Assessment of lung function, symptoms, and exacerbation outcomes
Inhaled pharmacotherapy led to improvement in lung function
Patients reported fewer symptoms
Reduced rates of exacerbation incidents were observed
No significant safety concerns were identified
Abstract
Regular inhaled pharmacotherapy improved lung function, symptoms, and exacerbation outcomes in pneumoconiosis with airway obstruction without added safety concerns.